Cargando…

Surface Plasmon Resonance Immunosensor with Antibody-Functionalized Magnetoplasmonic Nanoparticles for Ultrasensitive Quantification of the CD5 Biomarker

[Image: see text] A surface plasmon resonance (SPR) immunosensor signal amplification strategy based on antibody-functionalized gold-coated magnetic nanoparticles (mAuNPs) was developed for ultrasensitive and quantitative detection of the CD5 biomarker using an indirect sandwich immunoassay format....

Descripción completa

Detalles Bibliográficos
Autores principales: Kausaite-Minkstimiene, Asta, Popov, Anton, Ramanaviciene, Almira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100489/
https://www.ncbi.nlm.nih.gov/pubmed/35499973
http://dx.doi.org/10.1021/acsami.2c02936
_version_ 1784706857892315136
author Kausaite-Minkstimiene, Asta
Popov, Anton
Ramanaviciene, Almira
author_facet Kausaite-Minkstimiene, Asta
Popov, Anton
Ramanaviciene, Almira
author_sort Kausaite-Minkstimiene, Asta
collection PubMed
description [Image: see text] A surface plasmon resonance (SPR) immunosensor signal amplification strategy based on antibody-functionalized gold-coated magnetic nanoparticles (mAuNPs) was developed for ultrasensitive and quantitative detection of the CD5 biomarker using an indirect sandwich immunoassay format. The gold surface of the SPR sensor disk and mAuNPs was modified with a self-assembled monolayer of 11-mercaptoundecanoic acid (11-MUA), and the coupling method using N-(3-(dimethylamino)propyl)-N′-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide was used to immobilize capture antibodies against human CD5 (anti-CD5(2A)) and detection antibodies against human CD5 (anti-CD5(2B)), respectively. The mAuNPs and anti-CD5(2B) conjugates (mAuNPs–anti-CD5(2B)) were separated by an external magnetic field and used to amplify the SPR signal after the formation of the anti-CD5(2A)/CD5 immune complex on the SPR sensor disk. Compared to the direct CD5 detection with a limit of detection (LOD) of 1.04 nM and a limit of quantification (LOQ) of 3.47 nM, the proposed sandwich immunoassay utilizing mAuNPs–anti-CD5(2B) significantly improved the LOD up to 8.31 fM and the LOQ up to 27.70 fM. In addition, it showed satisfactory performance in human blood serum (recovery of 1.04 pM CD5 was 109.62%). These results suggest that the proposed signal amplification strategy has superior properties and offers the potential to significantly increase the sensitivity of the analysis.
format Online
Article
Text
id pubmed-9100489
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-91004892022-05-14 Surface Plasmon Resonance Immunosensor with Antibody-Functionalized Magnetoplasmonic Nanoparticles for Ultrasensitive Quantification of the CD5 Biomarker Kausaite-Minkstimiene, Asta Popov, Anton Ramanaviciene, Almira ACS Appl Mater Interfaces [Image: see text] A surface plasmon resonance (SPR) immunosensor signal amplification strategy based on antibody-functionalized gold-coated magnetic nanoparticles (mAuNPs) was developed for ultrasensitive and quantitative detection of the CD5 biomarker using an indirect sandwich immunoassay format. The gold surface of the SPR sensor disk and mAuNPs was modified with a self-assembled monolayer of 11-mercaptoundecanoic acid (11-MUA), and the coupling method using N-(3-(dimethylamino)propyl)-N′-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide was used to immobilize capture antibodies against human CD5 (anti-CD5(2A)) and detection antibodies against human CD5 (anti-CD5(2B)), respectively. The mAuNPs and anti-CD5(2B) conjugates (mAuNPs–anti-CD5(2B)) were separated by an external magnetic field and used to amplify the SPR signal after the formation of the anti-CD5(2A)/CD5 immune complex on the SPR sensor disk. Compared to the direct CD5 detection with a limit of detection (LOD) of 1.04 nM and a limit of quantification (LOQ) of 3.47 nM, the proposed sandwich immunoassay utilizing mAuNPs–anti-CD5(2B) significantly improved the LOD up to 8.31 fM and the LOQ up to 27.70 fM. In addition, it showed satisfactory performance in human blood serum (recovery of 1.04 pM CD5 was 109.62%). These results suggest that the proposed signal amplification strategy has superior properties and offers the potential to significantly increase the sensitivity of the analysis. American Chemical Society 2022-05-02 2022-05-11 /pmc/articles/PMC9100489/ /pubmed/35499973 http://dx.doi.org/10.1021/acsami.2c02936 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Kausaite-Minkstimiene, Asta
Popov, Anton
Ramanaviciene, Almira
Surface Plasmon Resonance Immunosensor with Antibody-Functionalized Magnetoplasmonic Nanoparticles for Ultrasensitive Quantification of the CD5 Biomarker
title Surface Plasmon Resonance Immunosensor with Antibody-Functionalized Magnetoplasmonic Nanoparticles for Ultrasensitive Quantification of the CD5 Biomarker
title_full Surface Plasmon Resonance Immunosensor with Antibody-Functionalized Magnetoplasmonic Nanoparticles for Ultrasensitive Quantification of the CD5 Biomarker
title_fullStr Surface Plasmon Resonance Immunosensor with Antibody-Functionalized Magnetoplasmonic Nanoparticles for Ultrasensitive Quantification of the CD5 Biomarker
title_full_unstemmed Surface Plasmon Resonance Immunosensor with Antibody-Functionalized Magnetoplasmonic Nanoparticles for Ultrasensitive Quantification of the CD5 Biomarker
title_short Surface Plasmon Resonance Immunosensor with Antibody-Functionalized Magnetoplasmonic Nanoparticles for Ultrasensitive Quantification of the CD5 Biomarker
title_sort surface plasmon resonance immunosensor with antibody-functionalized magnetoplasmonic nanoparticles for ultrasensitive quantification of the cd5 biomarker
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100489/
https://www.ncbi.nlm.nih.gov/pubmed/35499973
http://dx.doi.org/10.1021/acsami.2c02936
work_keys_str_mv AT kausaiteminkstimieneasta surfaceplasmonresonanceimmunosensorwithantibodyfunctionalizedmagnetoplasmonicnanoparticlesforultrasensitivequantificationofthecd5biomarker
AT popovanton surfaceplasmonresonanceimmunosensorwithantibodyfunctionalizedmagnetoplasmonicnanoparticlesforultrasensitivequantificationofthecd5biomarker
AT ramanavicienealmira surfaceplasmonresonanceimmunosensorwithantibodyfunctionalizedmagnetoplasmonicnanoparticlesforultrasensitivequantificationofthecd5biomarker